Cardlytics, Inc. (CDLX)
Automate Your Wheel Strategy on CDLX
With Tiblio's Option Bot, you can configure your own wheel strategy including CDLX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CDLX
- Rev/Share 5.2559
- Book/Share 1.2358
- PB 1.4647
- Debt/Equity 3.444
- CurrentRatio 1.1894
- ROIC -0.6916
- MktCap 95029344.0
- FreeCF/Share -0.2403
- PFCF -7.6249
- PE -0.5265
- Debt/Assets 0.5981
- DivYield 0
- ROE -1.7236
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | CDLX | Evercore ISI | -- | In-line | -- | $4 | Oct. 11, 2024 |
| Downgrade | CDLX | Northland Capital | Outperform | Market Perform | -- | $5 | Aug. 16, 2024 |
News
Cardlytics: Underrecognized Margin Recovery; Strong Buy Reiterated
Published: May 26, 2025 by: Seeking Alpha
Sentiment: Positive
We maintain our Strong Buy on Cardlytics and issue a PT of $6, despite the near-term revenue reset and slower monetization from new partners. The Amex channel is a game-changer, offering high-margin, immediate profitability with minimal incremental OpEx, supporting a clear path to EBITDA recovery. EBP and platform diversification are driving structural margin expansion, de-risking revenue and opening new high-engagement verticals for scalable growth.
Read More
Cardlytics Launches Cardlytics Rewards Platform and Expands Publisher Base Beyond Financial Institutions
Published: May 20, 2025 by: Business Wire
Sentiment: Neutral
ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced the general availability of Cardlytics Rewards Platform (CRP), a new solution that provides publishers the opportunity to enhance their customer loyalty programs with card-linked offers. With CRP, a merchant with digital channels and a loyalty program can now become a publisher on the Cardlytics network and offer more value to their customers. Building on its longstanding leadership in financial media, Cardlytics is expand.
Read More
Cardlytics, Inc. (CDLX) Q1 2025 Earnings Call Transcript
Published: May 07, 2025 by: Seeking Alpha
Sentiment: Neutral
Cardlytics, Inc. (NASDAQ:CDLX ) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET Company Participants Nick Lynton - Chief Legal and Privacy Officer Amit Gupta - Chief Executive Officer Alexis DeSieno - Chief Financial Officer Conference Call Participants Jacob Stephan - Lake Street Luke Horton - Northland Capital Markets Robert Coolbrith - Evercore Cal Bartyzal - Craig-Hallum Operator Ladies and gentlemen, thank you for standing by, and welcome to the Cardlytics Inc. Q1 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded on Wednesday, May 7, 2025.
Read More
Cardlytics (CDLX) Reports Q1 Loss, Tops Revenue Estimates
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Negative
Cardlytics (CDLX) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.09 per share a year ago.
Read More
Class Action Filed Against Cardlytics, Inc. (CDLX) - March 25, 2025 Deadline to Join – Contact Levi & Korsinsky
Published: March 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX) of a class action securities lawsuit.
Read More
Shareholders that lost money on Cardlytics, Inc. (CDLX) should contact The Gross Law Firm about pending Class Action - CDLX
Published: March 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Cardlytics, Inc. (NASDAQ: CDLX).
Read More
Lost Money on Cardlytics, Inc.(CDLX)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
Published: March 20, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , March 20, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cardlytics, Inc. (NASDAQ: CDLX). Shareholders who purchased shares of CDLX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Read More
The Gross Law Firm Reminds Cardlytics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 – CDLX
Published: March 17, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, March 17, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Cardlytics, Inc. (NASDAQ: CDLX).
Read More
Shareholders that lost money on Cardlytics, Inc. (CDLX) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
Published: March 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, March 13, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX) of a class action securities lawsuit.
Read More
Contact Levi & Korsinsky by March 25, 2025 Deadline to Join Class Action Against Cardlytics, Inc. (CDLX)
Published: March 13, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / March 13, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=135782&wire=1 or contact Joseph E. Levi, Esq.
Read More
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
Published: March 13, 2025 by: PRNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Cardlytics To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Cardlytics between March 14, 2024 and August 7, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , March 13, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cardlytics, Inc. ("Cardlytics" or …
Read More
Levi & Korsinsky Reminds Cardlytics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - CDLX
Published: March 11, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / March 11, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=135254&wire=1 or contact Joseph E. Levi, Esq.
Read More
Class Action Filed Against Cardlytics, Inc. (CDLX) Seeking Recovery for Investors - Contact Levi & Korsinsky
Published: March 10, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / March 10, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=135029&wire=1 or contact Joseph E. Levi, Esq.
Read More
Levi & Korsinsky Notifies Shareholders of Cardlytics, Inc.(CDLX) of a Class Action Lawsuit and an Upcoming Deadline
Published: March 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX) of a class action securities lawsuit.
Read More
Class Action Filed Against Cardlytics, Inc. (CDLX) - March 25, 2025 Deadline to Join - Contact Levi & Korsinsky
Published: March 10, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / March 10, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=134986&wire=1 or contact Joseph E. Levi, Esq.
Read More
CDLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Cardlytics, Inc. to Contact the Firm Today!
Published: March 10, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / March 10, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Cardlytics securities between March 14, 2024 and August 7, 2024, both dates inclusive (the "Class Period").
Read More
Class Action Filed Against Cardlytics, Inc. (CDLX) - March 25, 2025 Deadline to Join – Contact Levi & Korsinsky
Published: March 07, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX) of a class action securities lawsuit.
Read More
CDLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cardlytics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
Published: March 07, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / March 7, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Cardlytics securities between March 14, 2024 and August 7, 2024, both dates inclusive (the "Class Period").
Read More
CDLX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cardlytics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
Published: March 06, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / March 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Cardlytics securities between March 14, 2024 and August 7, 2024, both dates inclusive (the "Class Period").
Read More
CDLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cardlytics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
Published: March 05, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / March 5, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Cardlytics securities between March 14, 2024 and August 7, 2024, both dates inclusive (the "Class Period").
Read More
CDLX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cardlytics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
Published: March 04, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / March 4, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Cardlytics securities between March 14, 2024 and August 7, 2024, both dates inclusive (the "Class Period").
Read More
Cardlytics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - CDLX
Published: March 03, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / March 3, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=133645&wire=1 or contact Joseph E. Levi, Esq.
Read More
CDLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cardlytics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published: March 03, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / March 3, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Cardlytics securities between March 14, 2024 and August 7, 2024, both dates inclusive (the "Class Period").
Read More
Class Action Filed Against Cardlytics, Inc. (CDLX) - March 25, 2025 Deadline to Join - Contact Levi & Korsinsky
Published: February 28, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / February 28, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=133135&wire=1 or contact Joseph E. Levi, Esq.
Read More
CDLX Investors Have Opportunity to Lead Cardlytics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Published: February 28, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , Feb. 28, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ: CDLX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 14, 2024 and August 7, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before March 25, 2025.
Read More
Investors Who Lost Money on Cardlytics, Inc. (CDLX) Should Contact Levi & Korsinsky About Pending Class Action - CDLX
Published: February 28, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / February 28, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=133048&wire=1 or contact Joseph E. Levi, Esq.
Read More
A Securities Fraud Lawsuit Has Been Filed Against Cardlytics, Inc. And Investors With Losses Are Urged To Contact The Schall Law Firm
Published: February 28, 2025 by: Accesswire
Sentiment: Neutral
LOS ANGELES, CA / ACCESS Newswire / February 28, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 14, 2024 and August 7, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before March 25, 2025.
Read More
CDLX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cardlytics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published: February 28, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / February 28, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Cardlytics securities between March 14, 2024 and August 7, 2024, both dates inclusive (the "Class Period").
Read More
Levi & Korsinsky Reminds Cardlytics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - CDLX
Published: February 28, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Feb. 28, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Cardlytics investors who were adversely affected by alleged securities fraud between March 14, 2024 and August 7, 2024.
Read More
Class Action Filed Against Cardlytics, Inc. (CDLX) Seeking Recovery for Investors - Contact Levi & Korsinsky
Published: February 27, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / February 27, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=132806&wire=1 or contact Joseph E. Levi, Esq.
Read More
About Cardlytics, Inc. (CDLX)
- IPO Date 2018-02-09
- Website https://www.cardlytics.com
- Industry Advertising Agencies
- CEO Mr. Amit Gupta
- Employees 440